Correlation Between Dermata Therapeutics and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and enGene Holdings Common, you can compare the effects of market volatilities on Dermata Therapeutics and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and EnGene Holdings.
Diversification Opportunities for Dermata Therapeutics and EnGene Holdings
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dermata and EnGene is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and EnGene Holdings go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and EnGene Holdings
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the EnGene Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 2.08 times less risky than EnGene Holdings. The stock trades about -0.09 of its potential returns per unit of risk. The enGene Holdings Common is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 692.00 in enGene Holdings Common on September 2, 2025 and sell it today you would earn a total of 99.00 from holding enGene Holdings Common or generate 14.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Dermata Therapeutics vs. enGene Holdings Common
Performance |
| Timeline |
| Dermata Therapeutics |
| enGene Holdings Common |
Dermata Therapeutics and EnGene Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and EnGene Holdings
The main advantage of trading using opposite Dermata Therapeutics and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.| Dermata Therapeutics vs. BlackRock Investment Quality | Dermata Therapeutics vs. Canlan Ice Sports | Dermata Therapeutics vs. AG Mortgage Investment | Dermata Therapeutics vs. AG Mortgage Investment |
| EnGene Holdings vs. GRI Bio | EnGene Holdings vs. Prime Medicine, Common | EnGene Holdings vs. Zenas BioPharma, Common | EnGene Holdings vs. FT Vest Equity |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |